Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. Acalabrutinib

   TG THERAPEUTICS, INC.

   Chronic Lymphocytic Leukemia

   phase 2 · small molecule · active

   1 trial →

2. Acido Acetilsalicilico Teva Italia compresse...

   Fondazione Telethon ETS

   Patients scheduled for major surgery for oncologic indication

   phase 2 · small molecule · active

   1 trial →

3. Ad-RTS-hIL-12

   Alaunos Therapeutics

   Metastatic Breast Cancer

   phase 2 · mab · terminated

   1 trial →

4. Ad-RTS-hIL-12

   Alaunos Therapeutics

   Pediatric Brain Tumor

   phase 2 · mab · terminated

   1 trial →

5. Ad-RTS-hIL-12 and Veledimex

   Alaunos Therapeutics

   Breast Cancer Nos Metastatic Recurrent

   phase 2 · gene therapy · terminated

   1 trial →

6. Adaptive-Planning Organ Localisation (A-POLO) (Planning CT scan)

   United Therapeutics Europe Ltd

   Bladder Cancer

   phase 2 · other · active

   1 trial →

7. Adebellizumab

   The First People's Hospital of Lianyungang

   Resectable Lung Non-Small Cell Carcinoma

   phase 2 · small molecule · active

   1 trial →

8. Adebrelimab

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Pancreatic Cancer

   phase 2 · small molecule · active

   1 trial →

9. Adebrelimab (PD-L1 inhibitor)

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Pancreatic Cancer Metastatic

   phase 2 · small molecule · active

   1 trial →

10. Adebrelimab+Albumin paclitaxel +Cisplatin

    The First People's Hospital of Lianyungang

    Locally Advanced Hypopharyngeal Cancer

    phase 2 · small molecule · active

    1 trial →

11. Aerobic exercise training

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 2 · other · completed

    1 trial →

12. Afatinib and Paclitaxel

    United Therapeutics Europe Ltd

    Esophageal Cancer

    phase 2 · small molecule · completed

    1 trial →

13. Afatinib once daily (OD)

    Boehringer Ingelheim

    Breast Neoplasms

    phase 2 · small molecule · completed

    1 trial →

14. Aflibercept

    Regeneron UK Limited

    Advanced Carcinoma

    phase 2 · small molecule · terminated

    1 trial →

15. Aglatimagene besadenovec

    Candel Therapeutics

    Non Small Cell Lung Cancer

    phase 2 · mab · active

    1 trial →

16. Aglatimagene besadenovec

    Candel Therapeutics

    Borderline Resectable Pancreatic Adenocarcinoma

    phase 2 · mab · active

    1 trial →

17. Albumin Paclitaxel

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

18. Aldesleukin

    Iovance Biotherapeutics B.V.

    Bone Sarcoma

    phase 2 · mab · active

    1 trial →

19. Alectinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Bone Cancer

    phase 2 · small molecule · active

    1 trial →

20. Alirocumab

    Regeneron UK Limited

    Non Small Cell Lung Cancer

    phase 2 · small molecule · on hold

    1 trial →

21. Alirocumab and Cemiplimab

    Regeneron UK Limited

    Non-small Cell Lung Cancer (NSCLC)

    phase 2 · other · active

    1 trial →

22. Alisertib

    PUMA BIOTECHNOLOGY, INC.

    Hormone Receptor Positive HER-2 Negative Breast Cancer

    phase 2 · small molecule · active

    1 trial →

23. Alisertib

    PUMA BIOTECHNOLOGY, INC.

    Small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

24. Alisertib

    Takeda

    Diffuse Large B-cell Lymphoma

    phase 2 · small molecule · completed

    1 trial →

25. Alisertib

    Takeda

    Acute Myelogenous Leukemia

    phase 2 · small molecule · completed

    1 trial →

26. Alisertib

    Takeda

    Adenocarcinoma of the Prostate

    phase 2 · small molecule · completed

    1 trial →

27. Alisertib

    Takeda

    Acute Myeloid Leukemia

    phase 2 · small molecule · completed

    1 trial →

28. Alisertib

    Takeda

    Ovarian Carcinoma

    phase 2 · small molecule · completed

    2 trials →

29. Alisertib

    Takeda

    Small Cell Lung Cancer

    phase 2 · small molecule · completed

    1 trial →

30. Alisertib

    PUMA BIOTECHNOLOGY, INC.

    Small Cell Lung Cancer ( SCLC )

    phase 2 · small molecule · active

    1 trial →

31. Alisertib (MLN8237)

    Takeda

    Diffuse Large B-Cell Lymphoma

    phase 2 · small molecule · completed

    1 trial →

32. Alitretinoin

    LIGAND PHARMACEUTICALS INC

    Sarcoma, Kaposi

    phase 2 · small molecule · completed

    2 trials →

33. Alkotinib Capsules

    Suzhou Zelgen Biopharmaceuticals Co.,Ltd

    ALK-positive Non-small Cell Lung Cancer

    phase 2 · small molecule · terminated

    1 trial →

34. Allogenic expanded Natural Killer Cells (AlloNK1)

    Hospital Authority, Hong Kong

    Nasopharyngeal Carcinoma (NPC)

    phase 2 · mab · active

    1 trial →

35. Almonertinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

36. Almonertinib

    The First People's Hospital of Lianyungang

    EGFR Positive Non-small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

37. Almonertinib

    The First People's Hospital of Lianyungang

    Non Small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

38. Almonertinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer Non-small Cell Stage IV

    phase 2 · small molecule · active

    1 trial →

39. Almonertinib 110 MG

    Chinese University of Hong Kong

    Rare Tumor

    phase 2 · small molecule · active

    1 trial →

40. AloCelyvir

    The George Institute

    mEtastatic Uveal Melanoma

    phase 2 · small molecule · active

    1 trial →

41. Alpelisib

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 · small molecule · completed

    1 trial →

42. Amcenestrant

    Sanofi Pasteur

    Breast Cancer Metastatic

    phase 2 · small molecule · terminated

    1 trial →

43. Ametinib combined with bevacizumab

    The First People's Hospital of Lianyungang

    Non-small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

44. Anlotinib

    The First People's Hospital of Lianyungang

    Non-Small-Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

45. Anlotinib and Sintilimab injection

    The First People's Hospital of Lianyungang

    Advanced Hepatocellular Carcinoma

    phase 2 · small molecule · active

    1 trial →

46. Anlotinib combined Docetaxel

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

47. Anlotinib plus Pemetrexed

    Henan Provincial People's Hospital

    Non-squamous Cell Non-Small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

48. Anlotinib+ Liposomal Doxorubicin

    The First People's Hospital of Lianyungang

    Sarcoma

    phase 2 · small molecule · active

    1 trial →

Frequently asked questions